Tobacco, Alcohol, and Processed Food Industries – Why Do Public Health Practitioners View Them So Differently? by Katherine Smith et al.
April 2016 | Volume 4 | Article 641
OpiniOn
published: 11 April 2016
doi: 10.3389/fpubh.2016.00064
Frontiers in Public Health | www.frontiersin.org
Edited by: 
Dan J. Graham, 
Colorado State University, USA
Reviewed by: 
Armin D. Weinberg, 
Baylor College of Medicine, USA; 
Rice University, USA; Texas 
A&M University, USA 
Edward J. Trapido, 
Louisiana State University Health 
Sciences Center New Orleans, USA
*Correspondence:
Oliver Razum  
oliver.razum@uni-bielefeld.de
Specialty section: 
This article was submitted to Public 
Health Education and Promotion, 
a section of the journal 
Frontiers in Public Health
Received: 05 January 2016
Accepted: 27 March 2016
Published: 11 April 2016
Citation: 
Smith K, Dorfman L, Freudenberg N, 
Hawkins B, Hilton S, Razum O and 
Weishaar H (2016) Tobacco, Alcohol, 
and Processed Food 
Industries – Why Do Public Health 
Practitioners View Them 
So Differently? 
Front. Public Health 4:64. 
doi: 10.3389/fpubh.2016.00064
Tobacco, Alcohol, and processed 
Food industries – Why Do public 
Health practitioners View Them  
So Differently?
Katherine Smith1 , Lori Dorfman 2 , Nicholas Freudenberg 3 , Benjamin Hawkins 4 ,  
Shona Hilton 5 , Oliver Razum 6* and Heide Weishaar 5
1 Global Public Health Unit, University of Edinburgh, Edinburgh, UK, 2 Berkeley Media Studies Group, Public Health Institute, 
and School of Public Health, University of California Berkeley, Berkeley, CA, USA, 3 City University New York School of Public 
Health, New York, NY, USA, 4 London School of Hygiene and Tropical Medicine, London, UK, 5 MRC/CSO Social and Public 
Health Sciences Unit, University of Glasgow, Glasgow, UK, 6 School of Public Health, Bielefeld University, Bielefeld, Germany
Keywords: tobacco, alcohol, processed food, obesity, prevention, health policy, non-communicable diseases
The epidemiological transition, the shift from infectious to chronic non-communicable diseases 
(NCDs), is well advanced in most European countries. Viewed from one perspective, we can under-
stand this by focusing on changes to people’s lifestyles and behaviors. However, a contrasting view 
draws attention to broader, social and environmental features that are unfavorable to health. The 
World Health Organization (WHO) slogan “Make the healthy choice the easier choice” attempts 
to bridge these two views. It not only recognizes the choices that individuals have in consuming 
healthier products or taking exercise but also seems to acknowledge that consumer “choices” are 
heavily influenced by other factors beyond the individual’s power. Among these factors are the strate-
gies that corporations pursue to make unhealthy choices more likely. Thus, public health is inevitably 
confronted with the question of how to interact with commercial interests when it comes to tackling 
the NCD epidemic.
The engagement of public health practitioners and researchers with tobacco industry is now 
highly controversial leading many scholars to eschew interactions with the industry (1). Reflecting 
this, many leading journals now refuse to publish tobacco industry funded research (2). Yet, many 
public health officials consider dealing with the processed food, soft drink, and alcohol industries 
as normal practice, treating them as legitimate partners in improving population health (3). What 
is the rationale behind such different approaches to dealing with these industries, given that their 
products have a significant adverse impact on population health and their business strategies use 
similar approaches when it comes to marketing, product design, policy influence, and challenging 
evidence of harm (4, 5)?
In part, the answer lies in the extensive research linking the consumption of tobacco products 
to a range of negative health outcomes and the activities of the tobacco industry (4). As a result of 
a series of internal leaks followed by litigation against major tobacco companies in the US, internal 
tobacco company documents have entered the public realm (6). These highlight that senior managers 
of tobacco companies have (among other things): lied about how addictive tobacco products are, 
worked to increase the addictiveness of products; targeted young children as new product “markets”; 
and worked to restrain policies that aim to limit tobacco consumption and the influence of tobacco 
companies [see, e.g., Ref. (7)]. These revelations led to the conceptualization of the tobacco industry 
as a key NCD “vector” (4). Public health efforts to denormalize tobacco have effectively undermined 
public and political legitimacy of tobacco industry actors in selected policy contexts, where industry 
representatives are increasingly excluded from tobacco control debates (8). However, the growing 
popularity of e-cigarettes is threatening the cohesion of the movement to control tobacco and 
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offering new avenues through which tobacco industry actors can 
access policy makers (9).
Processed food, alcohol, and soft drink industries tend to 
argue (as the tobacco industry used to claim) that it is the 
individual’s personal responsibility to choose healthier options, 
for example, by exercising, eating healthy diets, and reducing 
the intake of less healthy products. The CEO of PepsiCo, Indra 
Nooyi, has, for example, argued that PepsiCo is an “ethical” 
company. She pointed out that her company offers a selection 
of products, ranging from healthy to less healthy. This view is 
frequently reinforced through advertising, news stories and 
television programs and, in many cases, government policies. 
From this perspective, considering the corporate interests 
relating to the production and marketing of products as social 
determinants of NCDs makes sense. However, these actors often 
portray themselves as “part of the solution” (10) to the health 
crises that their products exacerbate. Thus, the development of 
reformulated products, changes to labeling, support for “edu-
cational” initiatives, and the implementation of self-regulatory 
codes of practice are framed as appropriate strategies toward 
the control of NCDs.
The health harms associated with the tobacco, alcohol, and 
processed food industries are significant. Research shows that 
alcohol and obesity contribute significantly to unfavorable health 
outcomes (e.g., in pregnancy), often in a magnitude comparable 
to that of tobacco (4, 11). Evidence also suggests that the health-
related costs of products across these industries are similar and 
are perhaps highest for obesity (4, 12), rather than for tobacco. It 
is also clear that commercial interests and strategies across these 
sectors are similar, with industry representatives actively working 
to influence public and policy debates with a view to minimize 
the potential for regulation and maximize profit. Three examples 
suffice as follows:
•	 Recent research examining how alcohol industry actors in the 
UK have attempted to block policy proposals for minimum 
unit pricing identify strategies for policy influence that have 
been widely used by the tobacco industry, including efforts 
to shape the available evidence base (and the public’s, the 
media’s, and policymakers’ understandings of the available 
evidence), direct and indirect lobbying, links to more credible 
organizations such as think tanks, and efforts to shape public 
perceptions of the industry (13), often via the media (14).
•	 Corporate social responsibility (CSR) strategies are employed 
across all of these industries as means of shaping political 
contexts and informing public perceptions and consumption 
patterns. Despite these efforts to enhance their credibility, 
however, soda companies behave irresponsibly, for example, 
by explicitly targeting children and setting goals to increase 
consumption (15).
•	 In 2009–2012, a coalition of more than 50 food and beverage 
companies in the US invested US-$175 million to successfully 
lobby the Obama Administration not to pursue tougher (albeit 
still voluntary) nutritional standards for food items marketed 
to children (5).
Why then, in light of such striking similarities, do people 
appear to view the tobacco industry so differently to processed 
food, soft drinks, and alcohol industries? It may be, as Collin (1) 
argues – partly a consequence of the success of the tobacco con-
trol movement in promoting “tobacco exceptionalism”  –  the 
idea that the tobacco industry – as a result of both the health 
costs of tobacco products and our knowledge about prior 
industry behavior – requires a uniquely strict approach to pro-
tecting public health policy from the interference of industry.
Although it may be argued that tobacco is a uniquely harmful 
product – when used precisely as intended by manufacturers, 
tobacco will kill 50% of long-term users – a growing body of 
research suggests that the industry which produces it is far 
from unique as a vector of disease. Given the magnitude of 
the public health challenge posed by NCDs, we need to move 
beyond identifying the current, contradictory approaches to 
these different industries. We propose four priorities for public 
health research. They should help us to better comprehend how 
these key industries are perceived, and how they influence the 
way politics and the public accepts them and their strategies. 
Researchers must:
 1. develop tools to better understand how processed food, soft 
drinks, and alcohol industries influence public, media, politi-
cal, and policy debates,
 2. examine how policymakers, journalists, and the public view 
each of these industries and the products they market, and 
why,
 3. consider how research in this area might support policies 
that are effective and evidence informed, and will contribute 
toward promoting and protecting the public’s health, and
 4. investigate the complex network of actors that constitute 
each of these distinct industries and identify any interactions 
between them. In this way, we can elucidate interests, strate-
gies, and actions that are common across industries.
In moving this agenda forward, public health researchers need 
to make space for developing “charismatic ideas” – convincing 
alternative scenarios of a healthier future (5). This is necessary to 
identify possibilities and new avenues to reduce harmful corpo-
rate influences on health.
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